{
  "title": "Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)",
  "identifier": {
    "identifier": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY301",
    "identifierSource": "http://www.immport.org"
  },
  "producedBy": {  "name": "Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)",
  "performedBy": [
    {
      "firstName": "A. Karolina",
      "lastName": "Palucka",
      "email": "karolinap@baylorhealth.edu",
      "affiliations": [
          {
             "name": "Baylor Research Institute"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    }
  ],
  "studyGroups": [
        {
          "name": "AIRFV 2012-13",
          "size": 40
        }
  ],
  
  "usesReagent": [
        {
          "name": "AIRFV_BCELL_TUBE1"
        },
        {
          "name": "AIRFV_DC_TUBE2"
        },
        {
          "name": "AIRFV_TFH_TUBE3"
        },
        {
          "name": "GX-BeadChip HT12v4"
        },
        {
          "name": "Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/California/7/09 HA, NA (H1N1)"
        },
        {
          "name": "A/Victoria/361/2011 H3N2"
        },
        {
          "name": "B/Wisconsin/1/2010"
        },
        {
          "name": "A/Perth/16/2009 (H3N2)"
        },
        {
          "name": "B/Brisbane/60/2008"
        },
        {
          "name": "TRUSEQ RNA SAMPLE PREP KIT V2_Box A"
        },
        {
          "name": "TRUSEQ RNA SAMPLE PREP KIT V2_Box 1"
        },
        {
          "name": "TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined"
        },
        {
          "name": "TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box"
        },
        {
          "name": "Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3"
        },
        {
          "name": "Cluster generation_Flow cell_COUMKACXX/D16B4ACXX"
        },
        {
          "name": "Cluster generation_Manifold"
        },
        {
          "name": "TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708"
        },
        {
          "name": "SBS reagents_SBS box 1_RGT2120666/RGT2167122"
        },
        {
          "name": "SBS reagents_SBS box 2_RGT2176218/REA0266475"
        },
        {
          "name": "SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987"
        },
        {
          "name": "Master Kit"
        }
  ],
  
  "selectionCriteria": [
        {
          "category": "Inclusion",
          "values": [
              "healthy adults between the ages of 21 and 58 will receive seasonal TIV and followed up for 3 vaccine seasons"
          ]
        }
  ],
  
  "types": [
      {
          "value": "Interventional"
      }
  ]
  },
  "creators": [
    {
      "firstName": "A. Karolina",
      "lastName": "Palucka",
      "email": "karolinap@baylorhealth.edu",
      "affiliations": [
          {
             "name": "Baylor Research Institute"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    },
    {
      "name": "Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans",
      "extraProperties": [
        {
          "category": "Catgory",
          "values": [
            {
              "value": "DAIT"
            }
          ]
        },
        {
          "category": "External Id",
          "values": [
            {
              "value": "AI089987"
            }
          ]
        },
        {
          "category": "Description",
          "values": [
            {
              "value": "Our goal is to identify early biomarkers of effective antibody responses to flu vaccination. Four aims are proposed to meet this goal: Aim 1: To establish the baseline immune profiles in healthy subjects. Aim 2: To establish the immune profiles of Flu vaccination in healthy subjects. Aim 3: To identify the molecular signatures of DC subset(s) in response to Flu vaccination. Aim 4: To identify the molecular signatures of activated monocytes in response to Flu vaccination. RELEVANCE (See instructions): Despite the success of vaccines, we understand little about how effective ones stimulate protective immune responses. We will study how the flu vaccine generates effective antibody responses. The goal is to identify the immune responses elicited by effective vaccines so that vaccines that aren't as effective can be improved. To do this, we will vaccinate healthy people with the flu vaccine and monitor their immune response following the vaccination.   http://projectreporter.nih.gov/project_info_details.cfm?aid=8691692&icde=23828587&ddparam=&ddvalue=&ddsub=&cr=3&csb=default&cs=ASC"
            }
          ]
        }
      ]
    }
  ],
  "types": [
      {
        "value": "Interventional"
      },
      {
        "value": "Vaccine Response"
      }
  ],
  "dates": [
      {
          "date": "2016-06-17",
          "type": {
              "value": "final_public_release_date"
          }
      }
  ],
  "availability": "Available for download after registration with ImmPort",
  "refinement": "Curated",
  "dimensions": [{
        "name": {
            "value": "Cellular Phenotype"
        },
        "description": "None",
        "types": [
            {
               "value": "Flow Cytometry"
            }
        ]
      },{
        "name": {
            "value": "Transcript Quantification"
        },
        "description": "None",
        "types": [
            {
               "value": "Array"
            }
        ]
      },{
        "name": {
            "value": "Neutralizing Antibody Titer"
        },
        "description": "None",
        "types": [
            {
               "value": "Hemagglutination Inhibition"
            }
        ]
      },{
        "name": {
            "value": "Neutralizing Antibody Titer"
        },
        "description": "None",
        "types": [
            {
               "value": "Virus Neutralization"
            }
        ]
      },{
        "name": {
            "value": "Transcript Quantification"
        },
        "description": "None",
        "types": [
            {
               "value": "Sequencing"
            }
        ]
      },{
        "name": {
            "value": "Transcript Quantification"
        },
        "description": "None",
        "types": [
            {
               "value": "Nanostring"
            }
        ]
      },{
        "name": {
            "value": "Hematology test"
        }
      },{
        "name": {
            "value": "Vaccination History"
        }
      }
      
  ],
  "isAbout": [
        {
          "name": "None"
        },
        {
          "name": "SDY-300_C2_NONE"
        },
        {
          "name": "AIRFV_12-13_Nano"
        }
  ],
  "distributions": [
      {
          "identifier": {
              "identifier": "SDY301",
              "identifierSource": "ImmPort"
          },
          "title": "Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)",
          "access": {
              "landingPage": "http://www.immport.org",
              "accessURL": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY301",
              "types": [
                  {
                      "value": "Download tab separated files"
                  },
                  {
                      "value": "Download MySQL files and schema"
                  }
              ],
              "authorizations": [
                {
                    "value": "Registraton with ImmPort required"
                }
              ]
          },
          "storedIn": {
              "name": "ImmPort",
              "types": [
                {
                  "value": "primary repository"
                }
              ]
         },
         "licenses": [
           {
             "name": "ImmPort User Agreement",
             "version": "1.0",
             "extraProperties": [
               {
                 "category": "Link to User Agreement",
                 "values": [
                   {
                     "value": "http://www.immport.org/agreement"
                   }
                 ]
               }
             ]
           }
         ]
      }
  ],
  "acknowledges": [
    {
      "identifier": {
        "identifier": ""
      },
      "name": "Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans",
      "extraProperties": [
        {
          "category": "Link",
          "values": [
            {
              "value": "http://projectreporter.nih.gov/project_info_details.cfm?aid=8259851&icde=23826717&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC"
            }
          ]
        }
      ]}
  ],
  "licenses": [
    {
      "name": "ImmPort User Agreement",
      "version": "1.0",
      "extraProperties": [
        {
          "category": "Link to User Agreement",
          "values": [
            {
              "value": "http://www.immport.org/agreement"
            }
          ]
        }
      ]
    }
  ],
  "description": "This project will contribute to the overall vision and goals of this U19 by analyzing the immune response to Flu vaccination in healthy individuals. The knowledge generated in this Project will be transferred to Projects 3-5 where immune effects of vaccination will be studied in patients with underlying immune system alterations."
}
